Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

World ADC London 2025

15th World ADC London will bring together over 1000 ADC enthusiasts to maximise the therapeutic index of antibody-drug conjugates (ADCs). This event, now in its [...]

Go to Top